COMMUNIQUÉS West-GlobeNewswire

Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017
04/12/2017
TUSTIN, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company focused on helping improve patient lives by providing high quality biologics manufacturing [...]
Opiant Pharmaceuticals, Inc. Reports Fiscal First Quarter 2018 Financial Results
04/12/2017
SANTA MONICA, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported [...]
Adamis Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to the FDA for New Product Candidate for the Treatment of Opioid Overdose
04/12/2017
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) (“Adamis”) announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug [...]
Sunesis Pharmaceuticals Announces Change in Leadership
04/12/2017
- Daniel Swisher Resigns as CEO Effective End of 2017; t o Remain with Sunesis as a Strategic Advisor - - Board Member Dayton Misfeldt Appointed Interim CEO Effective January 2018; Board Starting Retained Search for [...]
Tabula Rasa HealthCare Announces Proposed Offering of Common Stock
04/12/2017
MOORESTOWN, N.J., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ) (“TRHC”), a healthcare technology optimizing medication safety by deploying new medication risk mitigation digital [...]
Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting
04/12/2017
BURNABY, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ: XENE ), a clinical-stage biopharmaceutical company, today announced the presentation of a scientific poster entitled “ [...]
Allscripts to attend upcoming investor events
04/12/2017
CHICAGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) today announced that certain members of its management team will attend the following upcoming investor events: Citi Global Mizuho Investor [...]
Akari Therapeutics to Host Investor and Analyst Event During the 59th American Society of Hematology Meeting
04/12/2017
NEW YORK and LONDON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan [...]
Galectin Therapeutics to Present Results from Phase 2b NASH-CX Trial on December 5, 2017
04/12/2017
NORCROSS, Ga., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, will issue a press release announcing the results of its [...]
VALNEVA to Conduct Investor and Partnering Meetings during the Annual J.P. Morgan Healthcare Conference
04/12/2017
Valneva to Conduct Investor and Partnering Meetings during the Annual J.P. Morgan Healthcare Conference Lyon (France), December 4, 2017 - Valneva SE today announces that its senior management team will hold investor and [...]
VALNEVA rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference
04/12/2017
Valneva rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference Lyon (France), 4 décembre 2017 - Valneva SE annonce ce jour que son équipe dirigeante rencontrera investisseurs et [...]
Progressive Care Announces Uplist to OTCQB
04/12/2017
MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
Ossur Hf : Transactions in relation to share buyback program
04/12/2017
Announcement from Össur hf. No. 85/2017 Reykjavík, 4 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Genmab to Hold 2017 R&D Update
04/12/2017
Media Release R&D Update to be held live in Atlanta, Georgia Key Opinion Leaders to discuss daratumumab and tisotumab vedotin data Discussion of Genmab’s pipeline, 2017 progress & company goals for 2018 Meeting [...]
NAPA’s Dorina Leibu Named to Board of American Health Council
04/12/2017
MELVILLE, N.Y., Dec. 04, 2017 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) announced today that the American Health Council has elected Dorina Leibu, MD to its physician board. Dr. Leibu, an [...]
Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors
04/12/2017
Olaine, 2017-12-04 16:03 CET (GLOBE NEWSWIRE) -- Meetings are planned on December 5 in Warsaw, December 6 in Stockholm, December 7 in Helsinki, December 8 in Tallinn and December 11 in Vilnius. More than 20 meetings [...]
Internal CRA documents show intent to deny the disability tax credit to Canadians with type 1 diabetes
04/12/2017
OTTAWA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Diabetes Canada and JDRF join today in expressing disappointment after receiving a copy of an internal Canada Revenue Agency (CRA) email demonstrating that a decision was made [...]
Des documents internes de l’ARC démontrent l’intention de refuser aux Canadiens atteints de diabète de type 1 l’accès au crédit d’impôt pour personnes handicapées
04/12/2017
OTTAWA, 04 déc. 2017 (GLOBE NEWSWIRE) -- Diabète Canada et FRDJ désirent exprimer conjointement leur déception après avoir reçu copie d’un courriel interne de l’Agence du revenu du Canada (ARC) qui démontre qu’une [...]
Vascular Dynamics Appoints Ed Roschak CEO
04/12/2017
MOUNTAIN VIEW, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc. (VDI), a privately held medical device company which has developed an innovative treatment system for the treatment of hypertension, today [...]

Pages